EU High Court Bans Patents For Embryonic Stem Cells

Law360, New York (October 18, 2011, 6:25 PM EDT) -- The European Union's highest court handed stem cell researchers a defeat Tuesday, ruling that procedures using and subsequently destroying human embryos were not patentable.

In a preliminary judgment, the EU’s Court of Justice ruled processes destroying human embryos to obtain stem cells for research and diagnostic treatment were not patentable, saying patent law must be applied to safeguard the dignity and integrity of human life.

The court held in its ruling that European law “excludes an invention from patentability where … the subject matter of the...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.